BIOMAT Database Logo BIOMAT Database Logo

[Clinical evaluation of pyridinolcarbamate effect on patients with obliterating atherosclerosis (author's transl)]. 1976

K Roztocil, and I Oliva, and J Linhart, and I Prerovský, and Z Modr

UI MeSH Term Description Entries
D008297 Male Males
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D011727 Pyridinolcarbamate A drug that has been given by mouth in the treatment of atherosclerosis and other vascular disorders, hyperlipidemias, and thrombo-embolic disorders. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1408) Pyricarbate,2,6-Pyridinedimethanol-bis-(N-methylcarbamate),Anginin,Angioxine,Colesterinex,Duaxol,Duvaline,Gasparol,Lisator,Movecil,P-23,Parmidine,Prodectin,Sospitan,P 23,P23
D002219 Carbamates Derivatives of carbamic acid, H2NC( Carbamate,Aminoformic Acids,Carbamic Acids,Acids, Aminoformic,Acids, Carbamic
D005260 Female Females
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000368 Aged A person 65 years of age or older. For a person older than 79 years, AGED, 80 AND OVER is available. Elderly
D001162 Arteriosclerosis Obliterans Common occlusive arterial disease which is caused by ATHEROSCLEROSIS. It is characterized by lesions in the innermost layer (ARTERIAL INTIMA) of arteries including the AORTA and its branches to the extremities. Risk factors include smoking, HYPERLIPIDEMIA, and HYPERTENSION. Obliterans, Arteriosclerosis

Related Publications

K Roztocil, and I Oliva, and J Linhart, and I Prerovský, and Z Modr
[Blood lipid composition in patients with obliterating atherosclerosis in lower extremities (author's transl)].
February 1979, Casopis lekaru ceskych,
K Roztocil, and I Oliva, and J Linhart, and I Prerovský, and Z Modr
[Biopharmaceutical studies on pyridinolcarbamate. I. Effect of continuous pyridinolcarbamate administration on renal excretion of sulfonamides in rabbits (author's transl)].
November 1978, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Roztocil, and I Oliva, and J Linhart, and I Prerovský, and Z Modr
[HDL lipids in men with obliterating atherosclerosis of the lower extremities (author's transl)].
February 1981, Casopis lekaru ceskych,
K Roztocil, and I Oliva, and J Linhart, and I Prerovský, and Z Modr
[Biopharmaceutical studies on pyridinolcarbamate. IV. Effect of continuous pyridinolcarbamate administration on hypoglycemic activity of tolbutamide and chlorpropamide in rabbits (author's transl)].
July 1979, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Roztocil, and I Oliva, and J Linhart, and I Prerovský, and Z Modr
Prevention of experimental atherosclerosis with pyridinolcarbamate.
May 1969, American heart journal,
K Roztocil, and I Oliva, and J Linhart, and I Prerovský, and Z Modr
Treatment of atherosclerosis obliterans with pyridinolcarbamate.
July 1971, Japanese heart journal,
K Roztocil, and I Oliva, and J Linhart, and I Prerovský, and Z Modr
[Biopharmaceutical studies on pyridinolcarbamate. II. Isolation and identification of the urinary metabolites of pyridinolcarbamate in rabbits (author's transl)].
November 1978, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
K Roztocil, and I Oliva, and J Linhart, and I Prerovský, and Z Modr
Atherosclerosis-inhibiting effect of an antibradykinin agent, pyridinolcarbamate.
February 1966, American heart journal,
K Roztocil, and I Oliva, and J Linhart, and I Prerovský, and Z Modr
Clinical evaluation of the effect of pyridinolcarbamate (Anginin) on ischemic heart diseases.
July 1968, Japanese heart journal,
K Roztocil, and I Oliva, and J Linhart, and I Prerovský, and Z Modr
[Biopharmaceutical studies on pyridinolcarbamate. III. Effect of continuous pyridinolcarbamate administration on renal excretion of phenolsulfonphthalein, p-aminohippuric acid, mannitol and inulin in rabbits (author's transl)].
November 1978, Yakugaku zasshi : Journal of the Pharmaceutical Society of Japan,
Copied contents to your clipboard!